Hettiaratchy S, and Dziewulski P. ABC of burns Introduc- tion. BMJ 2004; 328:1366-1368.
NIH Consensus Development Panel on Impotence. JAMA 1993:270:83-90.
Feldman HA, Goldstein I, Hatzichristou DG, et al. Impo- tence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994;151:54-61.
Tantiwong A. Epidemiology of erectile dysfunction: Prev- alence and risk factor. In: Ratana-Olarn K, Leungwat- tanakij S, eds. Erectile dysfunction. Bangkok: Beyond Enterprise, 2001:17-26.
Ignarro LJ, Buga GM, Wood KS, et al. Endothelium- derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9.
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium- derived relaxing factor. Nature 1987;327:524-6
Paick J, Lue TF. Anatomy of the penis. In: Hashmat A, Das S, eds. The penis. Philadelphia: Lea & Febiger, 1993:13.
Fischer C, Gross J, Zuch J. Cycle of penile erections synchronous with dreaming (REM) sleep: preliminary report. Arch Gen Psychiatry 1965;12:29-45
Mallick HN, Manchanda SK, Kumar VM. Sensory modulation of the medial preoptic area neuronal activity by dorsal penile nerve stimulation in rats. J Urol 1994;151:759-62
Melis MR, Argiolas A, Gessa GL. Evidence that apomor- phine induces penile erection and yawning by releasing oxytocin in the central nervous system. Eur J Pharmacol 1989;164:565-70
Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992;46:755-84.
Melis MR, Argiolas A. Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erec- tion and yawning in male rats. Brain Res Bull 1993;32:71-4.
Leungwattanakij S, Flynn V, Hellstrom WJG. Intracav- ernous and intraurethral therapy for erectile dysfunction. Urol Clin of North Am 2001;28(2):343-54.
Knowles RG, Noncada S. Nitric oxide synthases in mammals.Biochem J 1994;298:249-58.
Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-43.
Christ GJ, Moreno AP, Melman A, et al. Gap junction- mediated intercellular diffusion of Ca2 + in cultured human corporal smooth muscle cells. Am J Physiol 1992;263:C373-83.
Zusman RM, Morales A, Glasser DB, et al. Overall cardio- vascular profile of sildenafil citrate. Am J Cardiol 1999;83:35-44.
Goldstein I, Lue TF, Padma–Nathan H, et al. Oral silde- nafil in the treatment of erectile dysfunction. New Eng J Med 1998;338:1397-404.
Benet AE, Melman A.The epidemiology of erectile dysfunction. Urol Clin North Am 1995;22:699-709.
Rogers R, Meyer T, Lin CS, et al. Intracavernosal VEGF and AAA-VEGF gene prevent ED in a rat model of venous leakage impotence. Abstract presented in the 2000 Society for the Study of Impotence Fall Meeting, 2000.
Ratana-Olarn K. Impotence. In: Gojaseni P, Ratana-Olarn K, eds. Surgery of the urinary system and male genital organs, vol 2. Bangkok: Siam Stationary 1994: 226-251.
Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol 1997;158:1764-7.
Bradley WE, Timm GW, Gallagher JM, et al. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urol 1985;26:4-9.
Cilurzo P, Canale D, Turchi P, et al. The rigiscan system in the diagnosis of male sexual impotence. Arch Ital Urol Nefrol Androl 1992;64 (suppl 2):81-5.
Hattery RR, King BF Jr, Lewis RW, et al. Vasculogenic impotence. Duplex and color Doppler imaging. Radiol Clin North Am 1991;29:629-45.
Montorsi F, Guazzoni G, Barbieri L, et al. The effect of intracorporeal injection plus genital and audiovisual sexual stimulation versus second injection on penile color Doppler sonography parameters. J Urol 1996;155:536-40.
Zonszein J. Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am 1995;22:789-802.
Tantiwong A. Oral therapy for erectile dysfunction. In: Ratana-Olarn K, Leungwattanakij S, eds. Erectile dysfunction. Bangkok: Beyond Enterprise 2001:100-8.
Morales A, Gingell C, Colllins H, et al. Clinical safety of oral Sildenafil citrate in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74.
Leungwattanakij S. Future trend of management of erectile dysfunction. In: Ratana-Olarn K, Leungwattanakij S, eds. Erectile dysfunction. Bangkok: Beyond Enterprise 2001:168-79.
Claes H, Sorgeloose T, Van Poppel H, et al. Int J Impot Res 2002;14 (Suppl 3):CP5.01.
Hellstrom WJ, Bennett AH, Gesundheit N, et al. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil. Urol 1996;48:851-6.
Peterson CA, Bennett AH, Hellstrom WJ, et al. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations. J Urol 1998;159:1523-7.
Champion HC, Bivalacqua TJ, Wang R, et al. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat. J Urol 1999;161:2013-9.
Marmar JL. Vacuum constriction devices. In: Hellstrom WJG, ed. Male infertility and sexual dysfunction. New York: Springer-Verlag 1997:409-24.
Kongkanan A, Leungwattanakij S. Surgical treatment of erectile dysfunction. In: Ratana-Olarn K, Leungwat- tanakij S, eds. Erectile dysfunction. Bangkok: Beyond Enterprise 2001: 121-58.
Carson CC. Complication of penile prosthesis and complex implantations. In: Carson CC, Kirby RS, Goldstein IW, eds. Textbook of erectile dysfunction. Oxford: Isis Medical Media 1999:435-49.
Nehra A, Jones WR, Hakim L, et al. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 1999;11(Suppl1):C11.
Mydlo JH, Volpe MA, Macchia RJ. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol 2000;38:30-4.
Ho LV, Wang R, Mode DG, et al. Viagra and VCD. Int J Imp Res 1999;11(Suppl1):C10.
Kaplan SA, Reis RB, Kohn IJ, et al. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urol 1998;52:739-43.
McVary KT, Polepalle S, Riggi S, et al. Topical prosta- glandin E1 SEPA gel for the treatment of erectile dysfunction. J Urol 1999;162:726-30.
Becher E, Borghi M, Momesso A, et al. Penile hemody- namic findings with a new topical formulation of alprostadil. J Urol 1998;159(5)(Suppl):A915.
Leungwattanakij S, Bryan W, Hellstrom WJG. Androgen deficiency in aging male. Mediguide to Urology 2000;13:1-7.
Ballard SA, Gingell CJ, Tang K, et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodi- esterase isozymes. J Urol 1998;159(6):2164-71.
Phillips S, Gbekor E, Bethell S et al. Selectivity of Silde- nafiland other Phosphodiesterases Type 5 (PDE5) inhibi- tors against all human phosphodiesterase families. Euro Uro 2002;63 (Suppl.1):A244.
Hellstrom WJ, Hyun JS, Human L, et al. Antimicrobial activity of antibiotic-soaked, Resist trade mark-coated Bioflex®. Int J Impot Res 2003;15(1):18-21.
Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo- controlled trial. Eur Urol 2006;50:351-9.
Rajfer J, Aliotta PJ, Steidle CP, et al. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 2007;19:95-103.
Roehrborn CG, McVary KT, Elion-Mboussa A, et al. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 2008;180:1228-34.
Hellstrom WJ, Kaminetsky J, Belkoff LH, et al. Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study. J Urol 2015;194:485-92.
Paick JS, Ahn TY, Choi HK, et al. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med 2008;5: 2672-80.
Salem EA, Kendirci M, Hellstrom WJ. Udenafil, a long- acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs 2006;7:661-9.
Knoll LD, Henry G, Culkin D, et al. Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis. J Sex Med 2009;6:1773-8.
